Found: 17
Select item for more details and to access through your institution.
Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231221340
- By:
- Publication type:
- Article
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
- By:
- Publication type:
- Article
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).
- Published in:
- Annals of Hematology, 2024, v. 103, n. 4, p. 1305, doi. 10.1007/s00277-023-05573-z
- By:
- Publication type:
- Article
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 339, doi. 10.1007/s00277-023-05465-2
- By:
- Publication type:
- Article
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3195, doi. 10.1007/s00277-023-05427-8
- By:
- Publication type:
- Article
In situ XRD observation of CuO anode phase conversion in lithium-ion batteries.
- Published in:
- Journal of Materials Science, 2019, v. 54, n. 2, p. 1520, doi. 10.1007/s10853-018-2885-0
- By:
- Publication type:
- Article
Clinical Characteristics, Survival Outcomes and prognosis in 82 Immunoglobulin D Multiple Myeloma Patients: A Retrospective Single-Center Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e304, doi. 10.1016/j.clml.2019.09.499
- By:
- Publication type:
- Article
The impact of response kinetics following initial therapy for multiple myeloma in the era of novel agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e222, doi. 10.1016/j.clml.2019.09.370
- By:
- Publication type:
- Article
The prognostic impact of dynamic changing of cytogenetic abnormalities under the treatment options in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e221, doi. 10.1016/j.clml.2019.09.368
- By:
- Publication type:
- Article
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates the therapy-induced clonal selection in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e187, doi. 10.1016/j.clml.2019.09.313
- By:
- Publication type:
- Article
DNp73 promotes the proliferation and drug resistance of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e140, doi. 10.1016/j.clml.2019.09.234
- By:
- Publication type:
- Article
IgH translocations with undefined partners are associated with superior outcome in multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e82, doi. 10.1016/j.clml.2019.09.131
- By:
- Publication type:
- Article
The prognostic value of 1q21 gain does not rely on the copy numbers, clone size and concurrence with t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e62, doi. 10.1016/j.clml.2019.09.097
- By:
- Publication type:
- Article
PHF19 Promotes Drug Resistance via Increased EZH2 Phosphorylation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e21, doi. 10.1016/j.clml.2019.09.031
- By:
- Publication type:
- Article
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77450-y
- By:
- Publication type:
- Article
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 3, p. 421, doi. 10.1002/cncr.35056
- By:
- Publication type:
- Article